Interlynk has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 953169

June 21, 2024

Charité Clinicians Join InterLynk Workshop to Help Shape the Future of Biomaterials

Hands-on collaboration bridges research and clinical expertise to advance biomaterial innovation.

During the 7th General Assembly of the InterLynk project, a collaborative workshop brought together InterLynk researchers and clinicians from the Charité – Universitaetsmedizin Berlin hospital to explore the potential clinical applications of InterLynk’s newly developed biomaterials. The workshop, held in Berlin in June 2024, had a dual purpose: to introduce healthcare professionals with specialized knowledge in orthopedics and maxillofacial surgery to our innovations, and to gather their direct feedback. The participation of two orthopedic surgeons and two maxillofacial surgeons with diverse expertise provided valuable insights into how these materials could be optimized for the best clinical application, leveraging their deep knowledge of real-world clinical needs.

The session opened with a brief overview of the goals and scope of the InterLynk project, providing clinicians with a clear understanding of its objectives. Following this, the researchers conducted a hands-on demonstration, showing clinicians the process of creating biomaterials from hydrogel precursor solutions. The clinicians were also presented with 3D-printed biomaterials of varying strengths for evaluation.

The focus on the orthopedic and maxillofacial fields, where strong and versatile biomaterials are essential, highlighted the relevance of these innovations for future clinical applications. The main goal of the InterLynk project is to develop highly tailored multi-material scaffolds. These scaffolds are designed to synergistically promote the regeneration of interfacial, weight-bearing tissues and ensure optimal integration into the natural surroundings. Their expected clinical application will focus on the repair of multi-tissue defects in the temporomandibular joint, a critical area in maxillofacial surgery. Feedback from the clinicians was hence instrumental in refining the materials to meet the complex demands of such a sensitive area.

The workshop, held alongside the InterLynk General Assembly in Berlin, was an important step in ensuring that the biomaterials we are developing in InterLynk will be optimized to meet clinical requirements. This collaboration advanced the alignment of scientific innovation with practical medical applications, helping to fine-tune the materials for real-world surgical use.

 

Interlynk has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 953169

designed by promoscience

The product information you can find on this website is intended only for scientific researchers. Generic information related to medical conditions and their treatment is provided for informational purposes only and is not a substitute for qualified advice from a doctor or health care professional. Please do consult your professional healthcare provider for medical advice in case you are a patient or carer of a patient.
CONTENT WILL BE LOADED HERE
LEFT CONTENT WILL BE LOADED HERE
RIGHT CONTENT WILL BE LOADED HERE